基于结构的发现 核因子-kB合体 (RANKL) 受体激活剂 诱导骨质结晶发生抑制剂
Vagelis Rinotas1, Fotini Liepouri2, Maria-Dimitra Ouzouni3
1Institute for Bioinnovation, Biomedical Sciences Research Center "Alexander Fleming", 34 Fleming Street, 16672 Vari, Greece.
International journal of molecular sciences
|July 29, 2023
概括
研究人员发现了强大的骨质细胞形成抑制剂,骨质疏松症的关键过程. 三种化合物显示出明显的抑制与低毒性,为骨疾病提供有前途的治疗潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 核因子-kB连接体 (RANKL) 的受体激活剂对于骨再吸收至关重要,也是骨质疏松症的治疗点.
- RANKL促进骨质细胞分化,活性和生存,使其成为骨代谢的核心.
研究的目的:
- 确定针对RANKL诱导的骨质结晶发生的新型治疗剂.
- 为了发现具有强大的骨质结晶发生抑制和低毒性的化合物,用于治疗骨解病.
主要方法:
- 采用基于结构的虚拟查和实验评估来识别抑制性化合物.
- 合成和评估了30种用于抑制骨质细胞形成的有希望的支架的衍生品.
- 使用TRAP活性量化的抑制作用和评估的化合物毒性 (LC50).
主要成果:
- 在低微分子度 (IC50 <5μM) 抑制骨质结晶生成的11种商用化合物被确定.
- 三种化合物表现出高治疗指数与低毒性 (LC50 > 100μM).
- 另外四种衍生物显示出抑制潜力,但由于毒性问题而受到限制.
结论:
- 发现了具有多种支架的RANKL诱导骨质结晶发生的强有力的抑制剂.
- 识别了具有高治疗指数的化合物,适合于击中到引领的优化.
- 这些发现支持开发针对RANKL的骨解病的新疗法.
相关概念视频
Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


